New approaches to combat Porphyromonas gingivalis biofilms

References

• Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1–11.
   Web of Science ®Google Scholar
• De La Fuente-Núñez C, Reffuveille F, Fernández L, et al. Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol. 2013;16:580–589.
   PubMed Web of Science ®Google Scholar
• Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358:135–138.
   PubMed Web of Science ®Google Scholar
• Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2003;2:114–122.
   PubMed Web of Science ®Google Scholar
• Kolenbrander PE. Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol. 2000;54:413–437.
   PubMed Web of Science ®Google Scholar
• Aas JA, Paster BJ, Stokes LN, et al. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005;43:5721–5732.
   PubMed Web of Science ®Google Scholar
• Kolenbrander PE, Palmer RJ, Periasamy S, et al. Oral multispecies biofilm development and the key role of cell–cell distance. Nat Rev Microbiol. 2010;8:471–480.
   PubMed Web of Science ®Google Scholar
• How KY, Song KP, Chan KG. Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Front Microbiol. 2016;7:53.
   PubMed Web of Science ®Google Scholar
• Mahato N, Wu X, Wang L. Management of peri-implantitis: a systematic review, 2010-2015. Springerplus. 2016;5:105.
   Google Scholar
• Lamont RJ, Jenkinson HF. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev. 1998;62:1244–1263.
   PubMed Web of Science ®Google Scholar
• Holt SC, Kesavalu L, Walker S, et al. Virulence factors of Porphyromonas gingivalis. Periodontol. 2000;1999(20):168–238.
   Google Scholar
• Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8:623–633.
   PubMed Web of Science ®Google Scholar
• Lo AW, Seers CA, Boyce JD, et al. Comparative transcriptomic analysis of Porphyromonas gingivalis biofilm and planktonic cells. BMC Microbiol. 2009;9:18.
   PubMed Web of Science ®Google Scholar
• Enersen M, Nakano K, Amano A. Porphyromonas gingivalis fimbriae. J Oral Microbiol. 2013;5:1–10.
   Web of Science ®Google Scholar
• Hamada N, Watanabe K, Sasakawa C, et al. Construction and characterization of a fimA mutant of Porphyromonas gingivalis. Infect Immun. 1994;62:1696–1704.
   Web of Science ®Google Scholar
• Andrian E, Grenier D, Rouabhia M. Porphyromonas gingivalis-epithelial cell interactions in periodontitis. J Dent Res. 2006;85:392–403.
   PubMed Web of Science ®Google Scholar
• Kuboniwa M, Amano A, Inaba H, et al. Homotypic biofilm structure of Porphyromonas gingivalis is affected by FimA type variations. Oral Microbiol Immunol. 2009;24:260–263.
   Google Scholar
• Kuboniwa M, Amano A, Hashino E, et al. Distinct roles of long/short fimbriae and gingipains in homotypic biofilm development by Porphyromonas gingivalis. BMC Microbiol. 2009;9:105.
   PubMed Web of Science ®Google Scholar
• Goulbourne PA, Ellen RP. Evidence that Porphyromonas (Bacteroides) gingivalis fimbriae function in adhesion to Actinomyces viscosus. J Bacteriol. 1991;173:5266–5274.
   Web of Science ®Google Scholar
• Hashimoto M, Ogawa S, Asai Y, et al. Binding of Porphyromonas gingivalis fimbriae to Treponema denticola dentilisin. FEMS Microbiol Lett. 2003;226:267–271.
   PubMed Web of Science ®Google Scholar
• Lamont RJ, Bevan CA, Gil S, et al. Involvement of Porphyromonas gingivalis fimbriae in adherence to Streptococcus gordonii. Oral Microbiol Immunol. 1993;8:272–276.
   Google Scholar
• Maeda K, Nagata H, Yamamoto Y, et al. Glyceraldehyde-3-Phosphate dehydrogenase of Streptococcus oralis functions as a coadhesin for Porphyromonas gingivalis major fimbriae. Infect Immun. 2004;72:1341–1348.
   Web of Science ®Google Scholar
• Narimatsu M, Noiri Y, Itoh S, et al. Essential role for the gtfA gene encoding a putative glycosyltransferase in the adherence of Porphyromonas gingivalis. Infect Immun. 2004;72:2698–2702.
   Web of Science ®Google Scholar
• Park Y, Simionato MR, Sekiya K, et al. Short fimbriae of Porphyromonas gingivalis and their role in coadhesion with Streptococcus gordonii. Infect Immun. 2004;73:3983–3989.
   Web of Science ®Google Scholar
• Lin X, Wu J, Xie H. Porphyromonas gingivalis minor fimbriae are required for cell-cell interactions. Infect Immun. 2006;74:6011–6015.
   Web of Science ®Google Scholar
• Capestany CA, Tribble GD, Maeda K, et al. Role of the Clp system in stress tolerance, biofilm formation, and intracellular invasion in Porphyromonas gingivalis. J Bacteriol. 2008;190:1436–1446.
   Web of Science ®Google Scholar
• Wang B, Wu J, Lamont RJ, et al. Negative correlation of distributions of Streptococcus cristatus and Porphyromonas gingivalis in subgingival plaque. J Clin Microbiol. 2009;47:3902–3906.
   Web of Science ®Google Scholar
• Christopher AB, Arndt A, Cugini C, et al. A streptococcal effector protein that inhibits Porphyromonas gingivalis biofilm development. Microbiology. 2010;156:3469–3477.
   PubMed Web of Science ®Google Scholar
• Cugini C, Stephens DN, Nguyen D, et al. Arginine deiminase inhibits Porphyromonas gingivalis surface attachment. Microbiology. 2013;159:275–285.
   Web of Science ®Google Scholar
• Dixon DR, Darveau RP. Lipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid a structure. J Dent Res. 2005;84:584–595.
   PubMed Web of Science ®Google Scholar
• Nakao R, Senpuku H, Watanabe H. Porphyromonas gingivalis galE is involved in lipopolysaccharide O-antigen synthesis and biofilm formation. Infect Immun. 2006;74:6145–6153.
   PubMed Web of Science ®Google Scholar
• Capestany CA, Kuboniwa M, Jung I-Y, et al. Role of the Porphyromonas gingivalis InlJ protein in homotypic and heterotypic biofilm development. Infect Immun. 2006;74:3002–3005.
   Web of Science ®Google Scholar
• Davey ME, Duncan MJ. Enhanced biofilm formation and loss of capsule synthesis: deletion of a putative glycosyltransferase in Porphyromonas gingivalis. J Bacteriol. 2006;188:5510–5523.
   PubMed Web of Science ®Google Scholar
• Rosen G, Sela MN. Coaggregation of Porphyromonas gingivalis and Fusobacterium nucleatum PK 1594 is mediated by capsular polysaccharide and lipopolysaccharide. FEMS Microbiol Lett. 2006;256:304–310.
   PubMed Web of Science ®Google Scholar
• Saini R, Saini S, Sharma S. Biofilm: a dental microbial infection. J Nat Sci Biol Med. 2011;2:71–75.
   Google Scholar
• Chung WO, Park Y, Lamont RJ, et al. Signaling system in Porphyromonas gingivalis based on a LuxS protein. J Bacteriol. 2001;183:3903–3909.
   Web of Science ®Google Scholar
• Burgess NA, Kirke DF, Williams P, et al. LuxS-dependent quorum sensing in Porphyromonas gingivalis modulates protease and haemagglutinin activities but is not essential for virulence. Microbiology. 2002;148:763–772.
   PubMed Web of Science ®Google Scholar
• Schauder S, Shokat K, Surette MG, et al. The LuxS family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule. Mol Microbiol. 2016;4:463–476.
   Google Scholar
• McNab R, Ford SK, El-Sabaeny A, et al. LuxS-based signaling in Streptococcus gordonii: autoinducer 2 controls carbohydrate metabolism and biofilm formation with Porphyromonas gingivalis. J Bacteriol. 2003;185:274–284.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wright CJ, Dingming H, et al. Oral community interactions of Filifactor alocis in vitro. Plos One. 2013;8:e76271.
   PubMed Web of Science ®Google Scholar
• Fong KP, Chung WO, Lamont RJ, et al. Intra- and interspecies regulation of gene expression by Actinobacillus actinomycetemcomitans LuxS. Infect Immun. 2001;69:7625–7634.
   Web of Science ®Google Scholar
• Jang YJ, Choi YJ, Lee SH, et al. Autoinducer 2 of Fusobacterium nucleatum as a target molecule to inhibit biofilm formation of periodontopathogens. Arch Oral Biol. 2013;58:17–27.
   Web of Science ®Google Scholar
• Olczak T, Simpson W, Liu X, et al. Iron and heme utilization in Porphyromonas gingivalis. FEMS Microbiol Rev. 2005;29:119–144.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Dashper SG, Chen -Y-Y, et al. Porphyromonas gingivalis and Treponema denticola synergistic polymicrobial biofilm development. Plos One. 2013;8:e71727.
   PubMed Web of Science ®Google Scholar
• Kamaguchi A, Nakayama K, Ichiyama S, et al. Effect of Porphyromonas gingivalis vesicles on coaggregation of Staphylococcus aureus to oral microorganisms. Curr Microbiol. 2003;47:485–491.
   Web of Science ®Google Scholar
• Chen T, Nakayama K, Belliveau L, et al. Porphyromonas gingivalis gingipains and adhesion to epithelial cells. Infect Immun. 2001;69:3048–3056.
   Web of Science ®Google Scholar
• Han N, Whitlock J, Progulske-Fox A. The hemagglutinin gene A (hagA) of Porphyromonas gingivalis 381 contains four large, contiguous, direct repeats. Infect Immun. 1996;64:4000–4007.
   PubMed Web of Science ®Google Scholar
• Olczak T, Sroka A, Potempa J, et al. Porphyromonas gingivalis HmuY and HmuR: further characterization of a novel mechanism of heme utilization. Arch Microbiol. 2008;189:197–210.
   PubMed Web of Science ®Google Scholar
• Connolly E, Millhouse E, Doyle R, et al. The Porphyromonas gingivalis haemagglutinins HagB and HagC are major mediators of adhesion and biofilm formation. Mol Oral Microbiol. 2015. DOI:10.1111/omi.12151
   Web of Science ®Google Scholar
• Olczak T, Wójtowicz H, Ciuraszkiewicz J, et al. Species specificity, surface exposure, protein expression, immunogenicity, and participation in biofilm formation of Porphyromonas gingivalis HmuY. BMC Microbiol. 2010;10:134.
   PubMed Web of Science ®Google Scholar
• Butler CA, Dashper SG, Zhang L, et al. The Porphyromonas gingivalis ferric uptake regulator orthologue binds hemin and regulates hemin-responsive biofilm development. Plos One. 2014;9:e111168.
   Web of Science ®Google Scholar
• Grenier D. Nutritional interactions between two suspected periodontopathogens, Treponema denticola and Porphyromonas gingivalis. Infect Immun. 1992;60:5298–5301.
   PubMed Web of Science ®Google Scholar
• Yamada M, Ikegami A, Kuramitsu HK. Synergistic biofilm formation by Treponema denticola and Porphyromonas gingivalis. FEMS Microbiol Lett. 2005;250:271–277.
   PubMed Web of Science ®Google Scholar
• Philstrom BL. Periodontal risk assessment, diagnosis and treatment planning. Periodontol 2000. 2001;25:37–58.
   Web of Science ®Google Scholar
• Saini R, Saini S, Saini SR. Periodontitis: A risk for delivery of premature labor and low-birth-weight infants. J Nat Sci Biol Med. 2010;1:40–42.
   Google Scholar
• Eke PI, Dye BA, Wei L, et al. Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J Periodontol. 2015;86:611–622.
   PubMed Web of Science ®Google Scholar
• Preshaw PM, Alba AL, Herrera D, et al. Periodontitis and diabetes: a two-way relationship. Diabetologia. 2012;55:21–31.
   PubMed Web of Science ®Google Scholar
• Ata-Ali J, Candel-Marti ME, Flichy-Fernández AJ, et al. Peri-implantitis: associated microbiota and treatment. Med Oral Patol Oral Cir Bucal. 2011;16:e937–e943.
   PubMed Web of Science ®Google Scholar
• Zitzmann NU, Berglundh T. Definition and prevalence of peri-implant diseases. J Clin Periodontol. 2008;35:286–291.
   PubMed Web of Science ®Google Scholar
• Mombelli A, Müller N, Cionca N. The epidemiology of peri-implantitis. Clin Oral Implants Res. 2012;23:67–76.
   PubMed Web of Science ®Google Scholar
• Prakasam A, Elavarasu SS, Natarajan RK. Antibiotics in the management of aggressive periodontitis. J Pharm Bioallied Sci. 2012;4:S252–S255.
   PubMedGoogle Scholar
• Herrera D, Sanz M, Jepsen S, et al. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol. 2002;29:136–159.
   PubMed Web of Science ®Google Scholar
• Xajigeorgiou C, Sakellari D, Slini T, et al. Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis. J Clin Periodontol. 2006;33:254–264.
   PubMed Web of Science ®Google Scholar
• Van Winkelhoff AJ. Antibiotics in the treatment of peri-implantitis. Eur J Oral Implantol. 2012;5:43–50.
   Web of Science ®Google Scholar
• Prathapachandran J, Suresh N. Management of peri-implantitis. Dent Res J (Isfahan). 2012;9:516–521.
   PubMedGoogle Scholar
• Quirynen M, Teughels W, Van Steenberghe D. Microbial shifts after subgingival debridement and formation of bacterial resistance when combined with local or systemic antimicrobials. Oral Dis. 2003;9:30–37.
   Web of Science ®Google Scholar
• Balagopal S, Arjunkumar R. Chlorhexidine: the gold standard antiplaque agent. J Pharm Sci Res. 2013;5:270–274.
   Google Scholar
• Paolantonio M, Perinetti G, D’Ercole S, et al. Internal decontamination of dental implants: an in vivo randomized microbiologic 6-month trial on the effects of a chlorhexidine gel. J Periodontol. 2008;79:1419–1425.
   PubMed Web of Science ®Google Scholar
• Soskolne WA, Chajek T, Flashner M, et al. An in vivo study of the chlorhexidine release profile of the PerioChipTM in the gingival crevicular fluid, plasma and urine. J Clin Periodontol. 1998;25:1017–1021.
   PubMed Web of Science ®Google Scholar
• McBain AJ, Bartolo RG, Catrenich CE, et al. Effects of a chlorhexidine gluconate-containing mouthwash on the vitality and antimicrobial susceptibility of in vitro oral bacterial ecosystems. Appl Environ Microbiol. 2003;69:4770–4776.
   PubMed Web of Science ®Google Scholar
• Senel S, Ikinci G, Kaş S, et al. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int J Pharm. 2000;193:197–203.
   PubMed Web of Science ®Google Scholar
• Eley BM. Antibacterial agents in the control of supragingival plaque – a review. Br Dent J. 1999;186:286–296.
   PubMed Web of Science ®Google Scholar
• Kolahi J, Soolari A. Rinsing with chlorhexidine gluconate solution after brushing and flossing teeth: a systematic review of effectiveness. Quintessence Int. 2006;37:605–612.
   PubMed Web of Science ®Google Scholar
• Van Strydonck DA, Slot DE, Van der Velden U, et al. Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. J Clin Periodontol. 2012;39:1042–1055.
   PubMed Web of Science ®Google Scholar
• Kapoor A, Malhotra R, Grover V, et al. Systemic antibiotic therapy in periodontics. Dent Res J (Isfahan). 2012;9:505–515.
   Google Scholar
• Heitz-Mayfield LJ, Mombelli A. The therapy of peri-implantitis: a systematic review. Int J Oral Maxillofac Implants. 2014;29:325–345.
   PubMed Web of Science ®Google Scholar
• Keestra JA, Grosjean I, Coucke W, et al. Non-surgical periodontal therapy with systemic antibiotics in patients with untreated aggressive periodontitis: a systematic review and meta-analysis. J Periodontal Res. 2015;50:689–706.
   Web of Science ®Google Scholar
• Slots J, Ting M. Systemic antibiotics in the treatment of periodontal diseases. Periodontol. 2002;28:106–176.
   Google Scholar
• Jepsen K, Jepsen S. Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis. Periodontol. 2016;71:82–112.
   Google Scholar
• Rams TE, Degener JE, van Winkelhoff AJ. Antibiotic resistance in human peri-implantitis microbiota. Clin Oral Implants Res. 2014;25:82–90.
   Web of Science ®Google Scholar
• Rams TE, Degener JE, van Winkelhoff AJ. Antibiotic resistance in human chronic periodontitis microbiota. J Periodontol. 2014;85:160–169.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Noiri Y, Kuboniwa M, et al. Porphyromonas gingivalis biofilms persist after chlorhexidine treatment. Eur J Oral Sci. 2013;121:162–168.
   Web of Science ®Google Scholar
• Noiri Y, Okami Y, Narimatsu M, et al. Effects of Chlorhexidine, Minocycline, and Metronidazole on Porphyromonas gingivalis strain 381 in biofilms. J Periodontol. 2003;74:1647–1651.
   Web of Science ®Google Scholar
• Larsen T. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol Immunol. 2002;17:267–271.
   PubMedGoogle Scholar
• Asahi Y, Noiri Y, Igarashi J, et al. Synergistic effects of antibiotics and an N-acyl homoserine lactone analog on Porphyromonas gingivalis biofilms. J Appl Microbiol. 2012;112:404–411.
   PubMed Web of Science ®Google Scholar
• Shen Y, Stojicic S, Haapasalo M. Antimicrobial efficacy of chlorhexidine against bacteria in biofilms at different stages of development. J Endod. 2011;37:657–661.
   PubMed Web of Science ®Google Scholar
• Maezono H, Noiri Y, Asahi Y, et al. Antibiofilm effects of azithromycin and erythromycin on Porphyromonas gingivalis. Antimicrob Agents Chemother. 2011; 55:5887–5892.
   Web of Science ®Google Scholar
• Ardila CM, Granada MI, Guzmán IC. Antibiotic resistance of subgingival species in chronic periodontitis patients. J Periodontal Res. 2010;45:557–563.
   PubMed Web of Science ®Google Scholar
• van Winkelhoff AJ, Herrera Gonzales D, Winkel EG, et al. Antimicrobial resistance in the subgingival microflora in patients with adult periodontitis. A comparison between The Netherlands and Spain. J Clin Periodontol. 2000;27:79–86.
   PubMed Web of Science ®Google Scholar
• Kalia VC. Quorum sensing inhibitors: an overview. Biotechnol Adv. 2013;31:224–245.
   PubMed Web of Science ®Google Scholar
• Cho YJ, Song HY, Ben Amara H, et al. In vivo inhibition of Porphyromonas gingivalis growth and prevention of periodontitis with quorum-sensing inhibitors. J Periodontol. 2016;2:1075–1082.
   Google Scholar
• Lohan S, Bisht GS. Recent approaches in design of peptidomimetics for antimicrobial drug discovery research. Mini Rev Med Chem. 2013;13:1073–1088.
   Web of Science ®Google Scholar
• De Brucker K, Delattin N, Robijns S, et al. Derivatives of the mouse cathelicidin-related antimicrobial peptide (CRAMP) inhibit fungal and bacterial biofilm formation. Antimicrob Agents Chemother. 2014;58:5395–5404.
   PubMed Web of Science ®Google Scholar
• Wakabayashi H, Yamauchi K, Kobayashi T, et al. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia. Antimicrob Agents Chemother. 2009;53:3308–3316.
   PubMed Web of Science ®Google Scholar
• Wang H-Y, Cheng J-W, Yu H-Y, et al. Efficacy of a novel antimicrobial peptide against periodontal pathogens in both planktonic and polymicrobial biofilm states. Acta Biomater. 2015;25:150–161.
   PubMed Web of Science ®Google Scholar
• Li J, Wang X, Wang L, et al. High in vitro antibacterial activity of Pac-525 against Porphyromonas gingivalis biofilms cultured on titanium. Biomed Res Int. 2015;2015:909870–909878.
   Google Scholar
• Daep CA, James DM, Lamont RJ, et al. Structural characterization of peptide-mediated inhibition of Porphyromonas gingivalis biofilm formation. Infect Immun. 2006;74:5756–5762.
   Web of Science ®Google Scholar
• Lewis K. Platforms for antibiotic discovery. Nat Rev Drug Discov. 2013;12:371–387.
   PubMed Web of Science ®Google Scholar
• Labrecque J, Bodet C, Chandad F, et al. Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis. J Antimicrob Chemother. 2006;58:439–443.
   PubMed Web of Science ®Google Scholar
• La VD, Howell AB, Grenier D. Anti-Porphyromonas gingivalis and anti-inflammatory activities of A-type cranberry proanthocyanidins. Antimicrob Agents Chemother. 2010;54:1778–1784.
   Web of Science ®Google Scholar
• Kariu T, Nakao R, Ikeda T, et al. Inhibition of gingipains and Porphyromonas gingivalis growth and biofilm formation by prenyl flavonoids. J Periodontal Res. 2016. DOI:10.1111/jre.12372
   Web of Science ®Google Scholar
• Marquis A, Genovese S, Epifano F, et al. The plant coumarins auraptene and lacinartin as potential multifunctional therapeutic agents for treating periodontal disease. BMC Complement Altern Med. 2012;12:80.
   Web of Science ®Google Scholar
• Asahi Y, Noiri Y, Miura J, et al. Effects of the tea catechin epigallocatechin gallate on Porphyromonas gingivalis biofilms. J Appl Microbiol. 2014;2014(116):1164–1171.
   Google Scholar
• Bersan SMF, Galvão LCC, Goes VFF, et al. Action of essential oils from Brazilian native and exotic medicinal species on oral biofilms. BMC Complement Altern Med. 2014;14:451.
   Web of Science ®Google Scholar
• Solmaz G, Ozen F, Ekinci Y, et al. Inhibitory and disruptive effects of shiitake mushroom (Lentinula edodes) essential oil extract on oral biofilms. Jundishapur J Microbiol. 2013;6:1–6.
   Web of Science ®Google Scholar
• Ciandrini E, Campana R, Federici S, et al. In vitro activity of Carvacrol against titanium-adherent oral biofilms and planktonic cultures. Clin Oral Investig. 2014;18:2001–2013.
   PubMed Web of Science ®Google Scholar
• Sulistyani H, Fujita M, Miyakawa H, et al. Effect of roselle calyx extract on in vitro viability and biofilm formation ability of oral pathogenic bacteria. Asian Pac J Trop Med. 2016;9:119–124.
   Web of Science ®Google Scholar
• Zhou Y, Guan X, Zhu W, et al. Capsaicin inhibits Porphyromonas gingivalis growth, biofilm formation, gingivomucosal inflammatory cytokine secretion, and in vitro osteoclastogenesis. Eur J Clin Microbiol Infect Dis. 2014;33:211–219.
   Web of Science ®Google Scholar
• Feldman M, Grenier D. Cranberry proanthocyanidins act in synergy with licochalcone A to reduce Porphyromonas gingivalis growth and virulence properties, and to suppress cytokine secretion by macrophages. J Appl Microbiol. 2012;113:438–447.
   Web of Science ®Google Scholar
• Roberts JL, Khan S, Emanuel C, et al. An in vitro study of alginate oligomer therapies on oral biofilms. J Dent. 2013;41:892–899.
   Web of Science ®Google Scholar
• Costa EM. Antimicrobial effect of chitosan against periodontal pathogens biofilms. SOJ Microbiol Infect Dis. 2014;2:1–6.
   Google Scholar
• Van Loveren C. Sugar alcohols: what is the evidence for caries-preventive and caries-therapeutic effects? Caries Res. 2004;38:286–293.
   PubMed Web of Science ®Google Scholar
• Hashino E, Kuboniwa M, Alghamdi SA, et al. Erythritol alters microstructure and metabolomic profiles of biofilm composed of Streptococcus gordonii and Porphyromonas gingivalis. Mol Oral Microbiol. 2013;28:435–451.
   PubMed Web of Science ®Google Scholar
• Liebens V, Gerits E, Knapen WJ, et al. Identification and characterization of an anti-pseudomonal dichlorocarbazol derivative displaying anti-biofilm activity. Bioorg Med Chem Lett. 2014;24:5404–5408.
   Web of Science ®Google Scholar
• Wright CJ, Wu H, Melander RJ, et al. Disruption of heterotypic community development by Porphyromonas gingivalis with small molecule inhibitors. Mol Oral Microbiol. 2014;29:185–193.
   Web of Science ®Google Scholar
• Padhy BM, Gupta YK. Drug repositioning: re-investigating existing drugs for new therapeutic indications. J Postgrad Med. 2011;57:153–160.
   PubMed Web of Science ®Google Scholar
• Gerits E, Van Der Massen I, Vandamme K, et al. In vitro activity of the antiasthmatic drug zafirlukast against the oral pathogens Porphyromonas gingivalis and Streptococcus mutans. FEMS Microbiol Lett. 2017;364:fnx005.
   Web of Science ®Google Scholar
• Gerits E, Defraine V, De Cremer K, et al. Repurposing toremifene for the treatment of oral bacterial infections. Antimicrob Agents Chemother. 2017;61:e01846-e01816.
   Web of Science ®Google Scholar
• Gerits E, Spincemaille S, De Cremer K, et al. Repurposing AM404 for the treatment of oral infections by Porphyromonas gingivalis. Clin Exp Dental Res. Forthcoming.
   Web of Science ®Google Scholar
• Dashper S, Ang CS, Liu SW, et al. Inhibition of Porphyromonas gingivalis biofilm by oxantel. Antimicrob Agents Chemother. 2010;54:1311–1314.
   Web of Science ®Google Scholar
• Dashper S, O’Brien-Simpson N, Liu SW, et al. Oxantel disrupts polymicrobial biofilm development of periodontal pathogens. Antimicrob Agents Chemother. 2014;58:378–385.
   Web of Science ®Google Scholar
• Busscher HJ, van der Mei HC, Subbiahdoss G, et al. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci Transl Med. 2012;4:153rv10.
   PubMed Web of Science ®Google Scholar
• Holmberg KV, Abdolhosseini M, Li Y, et al. Bio-inspired stable antimicrobial peptide coatings for dental applications. Acta Biomater. 2013;9:8224–8231.
   PubMed Web of Science ®Google Scholar
• Yoshinari M, Kato T, Matsuzaka K, et al. Prevention of biofilm formation on titanium surfaces modified with conjugated molecules comprised of antimicrobial and titanium-binding peptides. Biofouling. 2010;26:103–110.
   PubMed Web of Science ®Google Scholar
• Shi J, Liu Y, Wang Y, et al. Biological and immunotoxicity evaluation of antimicrobial peptide-loaded coatings using a layer-by-layer process on titanium. Sci Rep. 2015;5:16336.
   PubMed Web of Science ®Google Scholar
• Mo AC, Xu W, Xian SQ, et al. Antibacterial activity of silver-hydroxyapatite/titania nanocomposite coating on titanium against oral bacteria. Key Eng Mater. 2007;330-332:455–458.
   Google Scholar
• Valappil SP, Coombes M, Wright L, et al. Role of gallium and silver from phosphate-based glasses on in vitro dual species oral biofilm models of Porphyromonas gingivalis and Streptococcus gordonii. Acta Biomater. 2012;8:1957–1965.
   Web of Science ®Google Scholar
• Sahdev R, Ansari TI, Higham SM, et al. Potential use of gallium-doped phosphate-based glass material for periodontitis treatment. J Biomater Appl. 2015;30:85–92.
   Web of Science ®Google Scholar
• Liu Y, Zhang X, Liu Y, et al. Bi-functionalization of a calcium phosphate-coated titanium surface with slow-release simvastatin and metronidazole to provide antibacterial activities and pro-osteodifferentiation capabilities. Plos One. 2014;9:e97741.
   PubMed Web of Science ®Google Scholar
• Seo M-D, Won H-S, Kim J-H, et al. Antimicrobial peptides for therapeutic applications: a review. Molecules. 2012;17:12276–12286.
   PubMed Web of Science ®Google Scholar
• Romanò CL, Scarponi S, Gallazzi E, et al. Antibacterial coating of implants in orthopaedics and trauma: a classification proposal in an evolving panorama. J Orthop Surg Res. 2015;10:157.
   PubMed Web of Science ®Google Scholar
• Klibanov AM. Permanently microbicidal materials coatings. J Mater Chem. 2007;17:2479–2482.
   Web of Science ®Google Scholar